HACKENSACK, N.J. and PETACH TIKVAH, Israel, Aug. 7, 2017 /PRNewswire/ --BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today the appointment of Mary Kay Turner to the position of Vice President of Patient Advocacy and Government Affairs, effective August 7, 2017. Ms. Turner joins BrainStorm from Mitsubishi Tanabe Pharma America, where she was Head of Patient Advocacy and Communications supporting the commercialization of edaravone (Radicava) for amyotrophic lateral sclerosis (ALS). Her prior industry experience includes senior sales leadership roles and she was Head of State Government Affairs and Advocacy for Bristol-Myers Squibb Company.
"We are pleased to have Mary Kay join our company as we advance our ALS clinical program and prepare to initiate Phase 3 testing of NurOwn," said Chaim Lebovits, President and Chief Executive Officer of BrainStorm Cell Therapeutics. "Having a strong patient advocacy perspective and voice in the community is integral to our mission of advancing tomorrow's medicines. Mary Kay brings an extensive background in patient advocacy, government affairs and health policy. We are fortunate to have someone with her biopharma expertise and dedication to the patient community join our team."
"Mary Kay will lead the development and implementation of external collaborations that will address and support the needs of people living with ALS", said Dr. Ralph Z. Kern, MD, MHSc, Chief Operating Officer and Chief Medical Officer of BrainStorm. "Working directly with patient advocacy groups deepens our understanding of patients' needs and aligns our efforts with the broader ALS community."
"I have been impressed by the progress BrainStorm has made with NurOwn, particularly the outstanding Phase 2 clinical data which showed meaningful improvements in disease symptoms," said Mary Kay Turner. "Joining the company at this exciting juncture provides a great opportunity to work with respected leaders in neurology and cell therapy and to contribute to the development of a new treatment that could potentially transform the ALS landscape."
Mary Kay is recognized as a leader within the biopharma industry for developing advocacy and government affairs strategies. Most recently she worked at Mitsubishi Tanabe Pharma America as Head of Patient Advocacy and Communications. Prior to this, Mary Kay spent 26 years at Bristol Myers Squibb Company where she played an essential role in establishing the company's advocacy function and held various positions of increasing responsibility in sales leadership, patient advocacy and government affairs. From 2010 to 2016, she was Head of State Government Affairs and Advocacy at Bristol-Myers. In this role she led a team of government affairs professionals that focused on significant legislative and regulatory issues that promoted and protected the discovery and development of innovative therapies. Mary Kay helped to define the company's advocacy strategy and engagement for each of its key therapeutic areas.
In 2016, Mary Kay was appointed to the Arizona Biomedical Research Commission by Arizona Governor Doug Ducey and served a one-year term.She was on the Board of Advisers for the International Cancer Advocacy Network (ICAN).Currently, Mary Kay is a member of the Board of Directors for the ALS Hope Foundation. She also served on the Board of Directors for Mental Health America for 3 years. Mary Kay has a Bachelor of Arts degree in Political Science and History from the University of Oregon.
About BrainStorm Cell Therapeutics Inc.
BrainStorm Cell Therapeutics Inc. is a biotechnology company engaged in the development of first-of-its-kind adult stem cell therapies derived from autologous bone marrow cells for the treatment of neurodegenerative diseases. The Company holds the rights to develop and commercialize its NurOwn technology through an exclusive, worldwide licensing agreement with Ramot, the technology transfer company of Tel Aviv University. NurOwn has been administered to approximately 75 patients with ALS in clinical trials conducted in the United States and Israel. In a randomized, double-blind, placebo-controlled clinical trial conducted in the U. S., a clinically meaningful benefit was demonstrated by higher response to NurOwn compared with placebo. For more information, visit the company's website at http://www.brainstorm-cell.com.
Radicava is a registered trademark of Mitsubishi Tanabe Pharma America.
ContactsMedia:Uri YablonkaChief Business OfficerBrainStorm Cell Therapeutics Inc.Phone: 646-666-3188rel="nofollow">uri@brainstorm-cell.com
Investors:Michael RiceLifeSci Advisors, LLCPhone: 646-597-6979rel="nofollow">mrice@lifesciadvisors.com
View original content with multimedia:http://www.prnewswire.com/news-releases/brainstorm-supports-commitment-to-als-patient-community-with-appointment-of-a-vice-president-of-patient-advocacy-and-government-affairs-300499934.html
SOURCE BrainStorm Cell Therapeutics Inc.
Excerpt from:
BrainStorm Supports Commitment to ALS Patient Community with ... - Markets Insider
- Arizona Oncology Cancer Center working with NexCore Group on new cancer treatment center - Yahoo Finance - October 13th, 2022
- Senate Passes 'Inflation Reduction Act' Which Will Likely Make Inflation Worse - Reason - August 14th, 2022
- Reds prospect rankings will shift after trade deadline acquisition of 10 players - The Athletic - August 5th, 2022
- Stem Cell Therapy Pros and Cons - Arizona Pain and Spine Institute - July 11th, 2022
- Bone Anatomy | Ask A Biologist - Arizona State University - July 11th, 2022
- No, "Top Gun" isn't an anti-woke success story, but rather a tribute to aging Tom Cruise and balls - Salon - June 4th, 2022
- Maine health care workers to appeal order to disclose their names in vaccine mandate lawsuit - Lewiston Sun Journal - June 4th, 2022
- BioEclipse Therapeutics Awarded Almost $8 Million Grant by California Institute for Regenerative Medicine (CIRM) to Fund Ongoing Phase 1 CRX100 Cancer... - May 2nd, 2022
- Right to Try 2.0: Ahwatukee family pushes for proposed law after getting medical treatment abroad - FOX 10 News Phoenix - April 6th, 2022
- Inside the real life Noahs Ark designed to save mankind after the apocalypse with a back up vault on t... - The US Sun - January 5th, 2022
- Human Embryonic Stem Cells - Arizona State University - November 22nd, 2021
- Mindy Kaling's 'The Sex Lives of College Girls' Is a Spot-On Depiction of College - Glamour - November 22nd, 2021
- Bridging the gap between online and on campus - ASU Now - November 22nd, 2021
- Bacterial Infections Linked with Unapproved Stem Cell Treatments - Contagionlive.com - October 28th, 2021
- ASU professor researches origins of Alzheimers to find a cure - Eight, Arizona PBS - October 16th, 2021
- City of Hope to Accelerate Blood Cancer Research Through a Transformational Gift from Leukemia Survivor James Belardi and His Wife Leslie Belardi -... - October 5th, 2021
- Calidi Biotherapeutics Announces Exclusive License Agreement with City of Hope and the University of Chicago for Novel Oncolytic Virotherapy... - August 18th, 2021
- Jim McMahon broke his neck playing for Vikings, and found out about it 17 years later - TwinCities.com-Pioneer Press - December 23rd, 2020
- Want to Know Where The Best Fall Colors Are in Your Area? Check Out This Interactive US Map - Good News Network - October 5th, 2020
- 'Were not your slaves': Alternative health providers bristle at warning letters about their coronavirus treatments - USA TODAY - September 4th, 2020
- Neogene precipitation, vegetation, and elevation history of the Central Andean Plateau - Science Advances - September 4th, 2020
- Research Roundup: Lasting Immunity to COVID-19 and More - BioSpace - August 21st, 2020
- What in the world is 'Project Carpaccio' and which Israeli company is doing business in Abu Dhabi? - CTech - August 21st, 2020
- Viruses have big impacts on ecology and evolution as well as human health - The Economist - August 21st, 2020
- Encouraging News About Coronavirus Immunity | In the Pipeline - Science Magazine - August 21st, 2020
- Scientists are seeing signs of lasting immunity to COVID-19, among survivors with even mild infections - Firstpost - August 21st, 2020
- Studies show positive signs of strong, lasting Covid-19 immunity - The Irish Times - August 21st, 2020
- Coronavirus vaccine will take time, so researchers are hunting for and finding promising new COVID-19 tre - OregonLive - April 6th, 2020
- Penn announces seven 2020 Thouron Award winners - Penn: Office of University Communications - February 24th, 2020
- Unlocking The Secrets Of DNA Help Researchers Understand How to Slow Aging - YouAreUNLTD - January 9th, 2020
- An ESPN reporter was diagnosed with HLH just before he died at age 34. What is it? - ABC15 Arizona - January 2nd, 2020
- 2020s visions: We'll get flying cars just before becoming software-based people - CNET - December 19th, 2019
- Man fights $4,600 surgery bill he was told insurance would cover - KGUN - December 8th, 2019
- Professor Recognized For Cardiac Regeneration Research - WPI News - December 8th, 2019
- Creative Medical Technology Holdings, Inc. Discusses CaverStem and Other Patented Technology with The Stock Day Podcast - Yahoo Finance - October 19th, 2019
- Bone marrow recipient comes face-to-face with CT donor for the first time - WTNH.com - October 19th, 2019
- Positive Study Results of Phase IIa Clinical Trial Using Intravenous Administration of Mesenchymal Stem Cells for Ischemic Stroke Published in... - October 1st, 2019
- Stem Cell Education Center - Stem Cell Treatment | Arizona ... - September 14th, 2019
- Stem Cell Therapy In Scottsdale Arizona | Regenerative ... - September 12th, 2019
- Stem Cell Therapy | Board Certified Orthopedic Surgeon ... - March 16th, 2019
- Stem Cell Lake Havasu City Arizona 86406 - March 8th, 2019
- Stem Cell Therapy for Cancer | Arizona Pain and Spine ... - December 18th, 2018
- Stem Cells | Arizona Pain Specialists - Scottsdale ... - December 11th, 2018
- Arizona Pain Regenerative Institute - Arizona Pain Specialists - December 5th, 2018
- Stem Cell Therapy Phoenix Arizona | Desert Health Specialists - December 4th, 2018
- Southwest Spine and Sports - Pain Management Doctor Arizona - September 24th, 2018
- Celebration Stem Cell Centre - A private umbilical cord ... - August 12th, 2018
- Bone marrow transplant - Mayo Clinic - July 15th, 2018
- About Dr. Nabil Dib - June 27th, 2018
- Around the world - Bend Bulletin - August 30th, 2017
- FDA Cracks Down On Stem-Cell Clinics Selling Unapproved Treatments - KNAU Arizona Public Radio - August 30th, 2017
- ASU grad students' lab skills help earn funding for cutting-edge biomedical research - Arizona State University - August 8th, 2017
- Will putting leeches on his face help this blind man see? - USA TODAY - August 8th, 2017
- Engineered Skin Cells Control Type 2 Diabetes in Mice: Study ... - Arizona Daily Star - August 8th, 2017
- 'Soft' side of bioengineering poised to make big impacts - Arizona State University - August 4th, 2017
- Tackling hard-to-treat cancers from every angle - Medical Xpress - June 21st, 2017
- ALS Research Forum | To Evaluate Stem Cell Therapies, Think ... - ALS Research Forum - June 20th, 2017
- New book by ASU researcher explores cancer's pervasive mysteries - Arizona State University - June 18th, 2017
- Arizona Supreme Court Clears Way For Adoption of American Indian Child by Non-Native Parents - Reason (blog) - June 15th, 2017
- Can We Cheat Death? US Firm Aims To Resurrect Brain-Dead People Using Stem Cells - International Business Times - June 11th, 2017
- The three cancers Jews need to worry about most and how to reduce the risks - Jewish Post - June 11th, 2017
- Patient-Centered Stem Cell Therapy Bill Passed by Texas Legislature - satPRnews (press release) - May 31st, 2017
- 6 Arizona young women are taking on the STEM gender gap - AZCentral.com - May 28th, 2017
- Scientists wary as Texas mulls allowing sale of unproven drugs - Texas Tribune - May 26th, 2017
- Scientists wary as Texas mulls allowing sale of unproven drugs - Bryan-College Station Eagle - May 24th, 2017
- ASU engineers envision 'guiding' body's cells to help improve health - Arizona State University - May 19th, 2017
- GV Gardeners: Sun-loving saguaro Southwest symbol | Sun Life ... - Sahuarita Sun (subscription) - May 19th, 2017
- Derek McCartney Named To Lott IMPACT Trophy Watch List - KKTV 11 News - May 18th, 2017
- Tucson Tech: University of Arizona startup advances living heart patch - Arizona Daily Star - May 15th, 2017
- Scientists uncover root of graying, thinning hair - Arizona Daily Star - May 15th, 2017
- GV Gardeners: Sun-loving saguaro Southwest symbol - Green Valley News - May 15th, 2017
- 7-year-old Hollis spread joy around U.S. After losing him to rare brain tumor, parents turn to finding cure - AZCentral.com - May 1st, 2017
- Young minds meet new technology at STEM-focused after-school program - USC News - April 19th, 2017
- Applications for Tissue Culture in Cannabis Growing: Part 1 - Cannabis Industry Journal (blog) - April 14th, 2017
- Yankees: James Kaprielian Getting Tommy John Surgery Out of the Way - Yanks Go Yard - April 14th, 2017
- Can Stem Cell 'Patch' Help Heart Failure? - Arizona Daily Star - April 9th, 2017
- Angels' focus is on defense - Reading Eagle - April 2nd, 2017
- Some restoration drama at the Big A as Dodgers top Angels, 3-1 - Los Angeles Times - April 1st, 2017
- Robert Clayton Robbins Top Choice for UA President - Arizona Public Media - March 10th, 2017
- R. William Funk Lands New Leader for University of Arizona - Hunt Scanlon Media (press release) - March 9th, 2017